Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ: 323990)
South Korea
· Delayed Price · Currency is KRW
13,910
-10 (-0.07%)
Oct 11, 2024, 9:00 AM KST
Vaxcell-Bio Therapeutics Market Cap
Vaxcell-Bio Therapeutics has a market cap or net worth of 324.66 billion as of October 11, 2024. Its market cap has decreased by -50.40% in one year.
Market Cap
324.66B
Enterprise Value
277.82B
Revenue
69.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
13,910.00
Market Cap Chart
Since September 22, 2020, Vaxcell-Bio Therapeutics's market cap has increased from 160.24B to 324.66B, an increase of 102.61%. That is a compound annual growth rate of 18.98%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 14, 2024 | 324.66B | -37.10% |
Dec 28, 2023 | 516.20B | -0.71% |
Dec 29, 2022 | 519.87B | -21.31% |
Dec 30, 2021 | 660.68B | -73.75% |
Dec 30, 2020 | 2,517.20B | 1,470.89% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition